Search:
Tokushima University ⟩ Graduate School of Biomedical Sciences ⟩ 医学域 ⟩ Medical Science ⟩ Internal Medicine ⟩ Department of Nephrology ⟩
Tokushima University ⟩ University Hospital ⟩ Clinical Division ⟩ Department of Internal Medicine ⟩ Nephrology ⟩
Tokushima University ⟩ Faculty of Medicine ⟩ School of Medicine ⟩ Course of Biological Medicine ⟩ Nephrology ⟩
Tokushima University ⟩ Graduate School of Medicine ⟩ Medicine ⟩ Course of Biological Medicine ⟩
Tokushima University ⟩ Research Clusters ⟩ Research Clusters ⟩ 2201003 プレシジョン栄養学の研究基盤確立を目指す食と栄養研究クラスター ⟩ 		(Files for researchmap) [PDF manual] [Auto-propagate to researchmap]

Research

Field of Study

○ Nephrology, Nutrition, Endocrinology and Metabolism

Subject of Study

○ 慢性腎臓病, 血液透析, エネルギー代謝

Book / Paper

Academic Paper (Judged Full Paper):

1. Norito Yoshimura, Katsutoshi Yamada, Takashi Ono, Mitsuru Notoya, Hideo Yukioka, Rina Takahashi, Shu Wakino, Takeshi Kanda and Hiroshi Itoh :
N-methyl-2-pyridone-5-carboxamide (N-Me-2PY) has potent anti-fibrotic and anti-inflammatory activity in a fibrotic kidney model: is it an old uremic toxin?,
Clinical and Experimental Nephrology, 2023.
(DOI: 10.1007/s10157-023-02379-1,   PubMed: 37490135)
2. Kan Kikuchi, Masaomi Nangaku, Munekazu Ryuzaki, Tomoyuki Yamakawa, Yoshihiro Ota, Norio Hanafusa, Ken Sakai, Yoshihiko Kanno, Ryoichi Ando, Toshio Shinoda, Shu Wakino, Hidetomo Nakamoto, Yoshiaki Takemoto and Tadao Akizawa :
Efficacy of molnupiravir and sotrovimab in Japanese dialysis patients with COVID-19 in clinical practice during the Omicron (BA.1 and BA.2) pandemic.,
Therapeutic Apheresis and Dialysis, 2023.
(DOI: 10.1111/1744-9987.14033,   PubMed: 37395555)
3. Kazuhiro Hasegawa, Yusuke Sakamaki, Masanori Tamaki and Shu Wakino :
PCK1 Protects against Mitoribosomal Defects in Diabetic Nephropathy in Mouse Models.,
Journal of the American Society of Nephrology, Vol.34, No.8, 1343-1365, 2023.
(DOI: 10.1681/ASN.0000000000000156,   PubMed: 37199399)
4. Ayumi Yoshifuji, Masataro Toda, Munekazu Ryuzaki, Emi Oyama, Kan Kikuchi, Toru Kawai, Ken Sakai, Masayoshi Koinuma, Kazuhiko Katayama, Takashi Yokoyama, Yuki Uehara, Norio Ohmagari, Yoshihiko Kanno, Hirofumi Kon, Toshio Shinoda, Yaoko Takano, Junko Tanaka, Kazuhiko Hora, Yasushi Nakazawa, Naoki Hasegawa, Norio Hanafusa, Fumihiko Hinoshita, Keita Morikane, Shu Wakino, Hidetomo Nakamoto and Yoshiaki Takemoto :
T-Cell Response and Antibody Production Induced by the COVID-19 Booster Vaccine in Japanese Chronic Kidney Disease Patients Treated with Hemodialysis.,
Vaccines, Vol.11, No.3, 2023.
(Tokushima University Institutional Repository: 118478,   DOI: 10.3390/vaccines11030653,   PubMed: 36992238)
5. Yoichi Oshima, Shu Wakino, Takeshi Kanda, Takaya Tajima, Tomoaki Itoh, Kiyotaka Uchiyama, Keiko Yoshimoto, Jumpei Sasabe, Masato Yasui and Hiroshi Itoh :
Sodium benzoate attenuates 2,8-dihydroxyadenine nephropathy by inhibiting monocyte/macrophage TNF-α expression.,
Scientific Reports, Vol.13, No.1, 2023.
(Tokushima University Institutional Repository: 118479,   DOI: 10.1038/s41598-023-30056-6,   PubMed: 36849798)
6. Ayumi Matsui, Ayumi Yoshifuji, Junichiro Irie, Takaya Tajima, Kiyotaka Uchiyama, Tomoaki Itoh, Shu Wakino and Hiroshi Itoh :
Canagliflozin protects the cardiovascular system through effects on the gut environment in non-diabetic nephrectomized rats.,
Clinical and Experimental Nephrology, Vol.27, No.4, 295-308, 2023.
(DOI: 10.1007/s10157-022-02312-y,   PubMed: 36611128)
7. Kunihisa Yamaguchi, Keisuke Ozaki, Tomoya Fukawa, Yutaro Sasaki, Shu Wakino and Masayuki Takahashi :
Drug-induced de novo thrombotic microangiopathy diagnosed 2 years after renal transplantation: A case report and literature review,
Renal Replacement Therapy, Vol.9, 1-6, 2023.
(DOI: 10.1186/s41100-022-00453-0)
8. Ayumi Yoshifuji, Masataro Toda, Munekazu Ryuzaki, Kan Kikuchi, Toru Kawai, Ken Sakai, Emi Oyama, Masayoshi Koinuma, Kazuhiko Katayama, Yuki Uehara, Norio Ohmagari, Yoshihiko Kanno, Hirofumi Kon, Toshio Shinoda, Yaoko Takano, Junko Tanaka, Kazuhiko Hora, Yasushi Nakazawa, Naoki Hasegawa, Norio Hanafusa, Fumihiko Hinoshita, Keita Morikane, Shu Wakino, Hidetomo Nakamoto and Yoshiaki Takemoto :
Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis.,
Renal Replacement Therapy, Vol.8, No.1, 2022.
(Tokushima University Institutional Repository: 118481,   DOI: 10.1186/s41100-022-00427-2,   PubMed: 35999867)
9. Makiko Ida-Naitoh, Hirobumi Tokuyama, Koji Futatsugi, Marie Yasuda, Keika Adachi, Takeshi Kanda, Yoshiyuki Tanabe, Shu Wakino and Hiroshi Itoh :
Proximal-tubule molecular relay from early Protein diaphanous homolog 1 to late Rho-associated protein kinase 1 regulates kidney function in obesity-induced kidney damage.,
Kidney International, Vol.102, No.4, 798-814, 2022.
(DOI: 10.1016/j.kint.2022.05.018,   PubMed: 35716954)
10. Kan Kikuchi, Masaomi Nangaku, Munekazu Ryuzaki, Tomoyuki Yamakawa, Ota Yoshihiro, Norio Hanafusa, Ken Sakai, Yoshihiko Kanno, Ryoichi Ando, Toshio Shinoda, Shu Wakino, Hidetomo Nakamoto, Yoshiaki Takemoto and Tadao Akizawa :
Effectiveness of SARS-CoV-2 vaccines on hemodialysis patients in Japan: A nationwide cohort study.,
Therapeutic Apheresis and Dialysis, Vol.27, No.1, 19-23, 2022.
(DOI: 10.1111/1744-9987.13887,   PubMed: 35610734)
11. Erina Sugita, Homare Sonoda, Masaki Ryuzaki, Akinori Hashiguchi, Hirobumi Tokuyama, Shu Wakino, Takeshi Kanda and Hiroshi Itoh :
Diagnosis of monoclonal immunotactoid glomerulopathy with positive λ chain by immunoelectron microscopy.,
CEN Case Reports, Vol.12, No.1, 7-13, 2022.
(DOI: 10.1007/s13730-022-00714-1,   PubMed: 35699924)
12. Ayumi Yoshifuji, Munekazu Ryuzaki, Yuki Uehara, Norio Ohmagari, Toru Kawai, Yoshihiko Kanno, Kan Kikuchi, Hiroshi Kon, Ken Sakai, Toshio Shinoda, Yaoko Takano, Junko Tanaka, Kazuhiko Hora, Yasushi Nakazawa, Naoki Hasegawa, Norio Hanafusa, Fumihiko Hinoshita, Keita Morikane, Shu Wakino, Hidetomo Nakamoto and Yoshiaki Takemoto :
Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy.,
Renal Replacement Therapy, Vol.8, No.1, 2022.
(Tokushima University Institutional Repository: 118486,   DOI: 10.1186/s41100-022-00405-8,   PubMed: 35494536)
13. Kiyotaka Uchiyama, Kohkichi Morimoto, Naoki Washida, Ei Kusahana, Takashin Nakayama, Tomoaki Itoh, Takahiro Kasai, Shu Wakino and Hiroshi Itoh :
Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial.,
International Urology and Nephrology, Vol.54, No.10, 2673-2681, 2022.
(DOI: 10.1007/s11255-022-03178-5,   PubMed: 35362819)
14. Keika Adachi, Kiyotaka Uchiyama, Kaori Muraoka, Takashin Nakayama, Marie Yasuda, Kazutoshi Miyashita, Hirobumi Tokuyama, Shu Wakino and Hiroshi Itoh :
Home-Based Exercise Program Ameliorates Renal Function Decline in Patients With CKD Stage 4.,
Kidney International Reports, Vol.7, No.4, 899-903, 2022.
(Tokushima University Institutional Repository: 118485,   DOI: 10.1016/j.ekir.2022.01.006,   PubMed: 35497789)
15. Kiyotaka Uchiyama, Keika Adachi, Kaori Muraoka, Takashin Nakayama, Takuma Oshida, Marie Yasuda, Akihito Hishikawa, Hitoshi Minakuchi, Kazutoshi Miyashita, Hirobumi Tokuyama, Shu Wakino and Hiroshi Itoh :
Home-based aerobic exercise and resistance training for severe chronic kidney disease: a randomized controlled trial.,
Journal of Cachexia, Sarcopenia and Muscle, Vol.12, No.6, 1789-1802, 2021.
(Tokushima University Institutional Repository: 118488,   DOI: 10.1002/jcsm.12775,   PubMed: 34554649)
16. Keika Adachi, Hirobumi Tokuyama, Yoichi Oshima, Tomoaki Itoh, Akinori Hashiguchi, Hiroyuki Yamakawa, Tadayasu Togawa, Hitoshi Sakuraba, Shu Wakino and Hiroshi Itoh :
Fabry disease associated with multiple myeloma: a case report.,
CEN Case Reports, Vol.11, No.1, 146-153, 2021.
(DOI: 10.1007/s13730-021-00613-x,   PubMed: 34529243)
17. Takashin Nakayama, Kiyotaka Uchiyama, Kohkichi Morimoto, Naoki Washida, Takahiro Kasai, Ran Nakamichi, Ei Kusahana, Shu Wakino and Hiroshi Itoh :
Efficacy of dexmedetomidine on peritoneal dialysis catheter insertion.,
International Urology and Nephrology, Vol.54, No.1, 209-215, 2021.
(DOI: 10.1007/s11255-021-02916-5,   PubMed: 34143371)
18. Itaru Yasuda, Kazuhiro Hasegawa, Yusuke Sakamaki, Hirokazu Muraoka, Takahisa Kawaguchi, Ei Kusahana, Takashi Ono, Takeshi Kanda, Hirobumi Tokuyama, Shu Wakino and Hiroshi Itoh :
Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.,
Journal of the American Society of Nephrology, Vol.32, No.6, 1355-1370, 2021.
(DOI: 10.1681/ASN.2020081188,   PubMed: 33795425)
19. Kaori Hayashi, Akinori Hashiguchi, Masako Ikemiyagi, Hirobumi Tokuyama, Shu Wakino and Hiroshi Itoh :
Development of nephropathy in an adult patient after Fontan palliation for cyanotic congenital heart disease.,
CEN Case Reports, Vol.10, No.3, 354-358, 2021.
(DOI: 10.1007/s13730-021-00573-2,   PubMed: 33476039)
20. Takahisa Kawaguchi, Kazuhiro Hasegawa, Itaru Yasuda, Hirokazu Muraoka, Hiroyuki Umino, Hirobumi Tokuyama, Akinori Hashiguchi, Shu Wakino and Hiroshi Itoh :
Diabetic condition induces hypertrophy and vacuolization in glomerular parietal epithelial cells.,
Scientific Reports, Vol.11, No.1, 2021.
(Tokushima University Institutional Repository: 118492,   DOI: 10.1038/s41598-021-81027-8,   PubMed: 33452384)
21. Itaru Yasuda, Hirobumi Tokuyama, Akinori Hashiguchi, Kazuhiro Hasegawa, Kiyotaka Uchiyama, Masaki Ryuzaki, Marie Yasuda, Ryuichi Mizuno, Shigeto Ishidoya, Shu Wakino and Hiroshi Itoh :
Malignancy-associated membranous nephropathy with PLA2R double-positive for glomeruli and carcinoma.,
CEN Case Reports, Vol.10, No.2, 281-286, 2021.
(DOI: 10.1007/s13730-020-00556-9,   PubMed: 33393071)
22. Takashin Nakayama, Kiyotaka Uchiyama, Naoki Washida, Kohkichi Morimoto, Kaori Muraoka, Keika Adachi, Takahiro Kasai, Kazutoshi Miyashita, Shu Wakino and Hiroshi Itoh :
Exercise Parameters Predict Technique Survival in Patients on Peritoneal Dialysis.,
Blood Purification, Vol.50, No.3, 380-389, 2020.
(Tokushima University Institutional Repository: 118494,   DOI: 10.1159/000511293,   PubMed: 33091919)
23. Hitoshi Minakuchi, Shu Wakino, Hidenori Urai, Arata Kurokochi, Kazuhiro Hasegawa, Takeshi Kanda, Hirobumi Tokuyama and Hiroshi Itoh :
The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial.,
Scientific Reports, Vol.10, No.1, 2020.
(Tokushima University Institutional Repository: 118495,   DOI: 10.1038/s41598-020-73638-4,   PubMed: 33024237)

Academic Paper (Unrefereed Paper):

1. 友 雅司, 峰島 三千男, Shu Wakino and 武本 佳昭 :
学術委員会血液浄化療法の機能・効率に関する小委員会報告 血液透析濾過器の性能評価と使い分け,
Journal of Japanese Society for Dialysis Therapy, Vol.56, No.3, 83-84, 2023.
(DOI: 10.4009/jsdt.56.83)

Review, Commentary:

1. Shu Wakino :
【腸腎連関に関する最近の話題】メタボリックシンドロームと腸腎連関,
Japanese Journal of Nephrology, Vol.65, No.2, 74-80, Mar. 2023.
2. Shu Wakino :
【高齢者の消化器疾患-最新の診断と治療-】消化器疾患-腎疾患相関への加齢への影響,
Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.81, No.2, 305-314, Feb. 2023.
3. Shu Wakino, Kazuhiro Hasegawa and Masanori Tamaki :
近位尿細管から見た糖尿病性腎臓病と肥満関連腎症,
Cardioangiology, Vol.93, No.2, 182-189, Feb. 2023.
(CiNii: 1520013962704009344)
4. Masanori Tamaki, Kazuhiro Hasegawa and Shu Wakino :
【急性腎障害(AKI)】AKIの病態とその対応 手術とAKI,
Kidney and Dialysis, Vol.94, No.1, 83-86, Jan. 2023.
5. Shu Wakino :
【腎臓症候群(第3版)-その他の腎臓疾患を含めて-】各種病態にみられる腎障害 肝疾患,消化管疾患 炎症性腸疾患に伴う腎障害,
Nihon Rinsho. Japanese Journal of Clinical Medicine, Vol.III, 254-258, Oct. 2022.
6. Masanori Tamaki and Shu Wakino :
透析患者の血圧はどこまで下げるべきでしょうか?,
Internal Medicine, Vol.130, No.3, 612-614, Sep. 2022.
7. Shu Wakino :
【栄養指導・管理のためのスキルアップシリーズ CKDの最新食事療法のなぜに答える-透析編】透析患者では，どのような微量元素が欠乏するリスクがあるでしょうか? それはなぜですか?食事療法で補えますか?,
臨床栄養, 62-67, Jul. 2022.
8. Kazuhiro Hasegawa and Shu Wakino :
【ポドサイトパチー】糖尿病性腎症におけるポドサイト傷害の見える化へ迫る最新論文,
Nephrology, Vol.15, No.6, 659-664, Jun. 2022.
(CiNii: 1520011108762623872)
9. Shu Wakino :
【予防医学からみた腎疾患診療】CKDの発症・進展と合併症のリスクとされるエビデンス 糖代謝異常 インスリン抵抗性と腎障害,
Kidney and Dialysis, Vol.92, No.5, 853-859, May 2022.
10. Kazuhiro Hasegawa, Masanori Tamaki, 坂巻 裕介 and Shu Wakino :
ミトコンドリアとSIRT1/NMNと腎臓病,
Nephrology, Vol.15, No.5, 551-557, May 2022.
(CiNii: 1520292395539278336)
11. Shu Wakino :
【かかりつけ医からみた糖尿病診療】糖尿病診療における合併症の管理 糖尿病性腎臓病,
診断と治療, Vol.110, No.3, 313-319, Mar. 2022.
12. Shu Wakino :
亜鉛欠乏症と慢性腎臓病,
Journal of Zinc Nutritional Therapy, Vol.12, No.2, 94-97, Mar. 2022.
13. Shaw Watanabe, Kyoka Adachi, Shu Wakino, Takahisa Hisada and Jun Mochizuki :
Dietary therapy with low protein genmai (brown rice) to improve the gut-kidney axis and reduce CKD progression.,
Asia Pacific Journal of Clinical Nutrition, Vol.31, No.3, 341-347, 2022.
(DOI: 10.6133/apjcn.202209_31(3).0001,   PubMed: 36173205)

Proceeding of International Conference:

1. Hamamoto Riko, Hirokazu Ohminami, Shu Wakino and Yutaka Taketani :
Effectiveness of protein restriction diet on chronic kidney disease: a systematic review,
The International Workshop on Gut-kidney Axis and Chronic Kidney Disease, Tokyo, Mar. 2023.

Proceeding of Domestic Conference:

1. Shu Wakino, 柴田 理恵子, Kazuhiro Hasegawa, Masanori Tamaki, Masanori Minato, Taizo Inagaki, 宮上 慎司, 多田 美穂 and Ichiro Hashimoto :
皮膚虚血・潰瘍病変患者における血中亜鉛濃度の意義,
第53回徳島透析療法研究会, Dec. 2023.
2. Shu Wakino :
糖尿病性腎症から慢性腎臓病治療への新規治療戦略,
四国医学雑誌, Vol.79, No.1-2, 132-133, Jun. 2023.
3. Kazuhiro Hasegawa, Masanori Tamaki and Shu Wakino :
心血管内分泌の新知見 尿細管糸球体連関とDKD,
Folia endocrinologica Japonica, Vol.99, No.1, 171, May 2023.
4. 古川 安志, 赤水 尚史, 佐藤 哲郎, 磯崎 収, 鈴木 敦詞, 飯降 直男, 坪井 久美子, Shu Wakino, 手良向 聡, 金本 巨哲, 三宅 吉博, 田中 景子, 木村 映善, 南谷 幹史 and 井口 守丈 :
甲状腺クリーゼ多施設前向きレジストリー研究の経過報告,
Folia endocrinologica Japonica, Vol.98, No.5, 1272, Mar. 2023.
5. Shu Wakino :
糖尿病性腎臓病の治療の進歩,
The Journal of the Japanese Society of Internal Medicine, Vol.112, 120-121, Feb. 2023.
6. 越智 ありさ, Akiko Sakurai, 太田 浩二, 飛永 恭兵, RYUYA Wakabayashi, Shu Wakino, Koichi Ute and Tatsuya Tominaga :
A new purification method for exosome, using highly water-absorbing polymer.,
第45回日本分子生物学会年会, Dec. 2022.
7. Yohjiroh Sunada, Sayo Ueda, Masanori Tamaki, Eriko Shibata and Shu Wakino :
胃癌による二次性血栓性微小血管症(TMA)の一例,
Shikoku Acta Medica, Vol.78, No.5-6, 257-258, Dec. 2022.
8. Kazuhiro Hasegawa, Masanori Tamaki and Shu Wakino :
時間空間的ネットワークで考えるDKDの基礎研究 尿細管糸球体クロストークとDKD,
Japanese Journal of Nephrology, Vol.64, No.6-W, 696, Oct. 2022.
9. Masanori Tamaki, 宮上 慎司, Ikuko Shimizu, 山口 純代, Masanori Minato, Sayo Ueda, Eriko Shibata, Kazuhiro Hasegawa and Shu Wakino :
ロキサデュスタット投与後に奇異性脳塞栓を発症した1例,
Japanese Journal of Nephrology, Vol.64, No.6-W, 719, Oct. 2022.
10. 宮上 慎司, Masanori Tamaki, Ikuko Shimizu, 山口 純代, Masanori Minato, Sayo Ueda, Eriko Shibata, Kazuhiro Hasegawa and Shu Wakino :
コロナウィルスワクチン後発症した悪性腎硬化症の一例,
Japanese Journal of Nephrology, Vol.64, No.6-W, 719, Oct. 2022.
11. Shu Wakino, 安達 京華, 渡邊 昌 and 伊藤 裕 :
低蛋白玄米の腎不全患者への効果,
New Diet Therapy, Vol.38, No.2, 223, Sep. 2022.
12. Shu Wakino, 安達 京華, 渡邊 昌 and 伊藤 裕 :
長野県佐久地域における健常腎保持者の摂取蛋白源に関する検討,
New Diet Therapy, Vol.38, No.2, 229, Sep. 2022.
13. Shu Wakino :
微量元素セレンの臨床的重要性,
The Japanese Journal of Surgical Metabolism and Nutrition, Vol.56, No.3, 117, Jun. 2022.
14. Kazuhiro Hasegawa, Masanori Tamaki, 坂巻 裕介 and Shu Wakino :
腎臓病治療に対する新たな切り口 DMミトコンドリア機能改善薬やNADがDKDのみならず腎臓病への切り口となる可能性,
Japanese Journal of Nephrology, Vol.64, No.3, 189, May 2022.
15. Shu Wakino, Kazuhiro Hasegawa and 伊藤 裕 :
DKDに立ち向かう-これまでの100年とこれからの未来- DKD基礎研究の歩みと先端医療,
Japanese Journal of Nephrology, Vol.64, No.3, 189, May 2022.
16. Kazuhiro Hasegawa, Masanori Tamaki, 坂巻 裕介 and Shu Wakino :
NMN消費酵素Nmnatのポドサイト発現調節はE-boxへのepigenetic制御が担う,
Japanese Journal of Nephrology, Vol.64, No.3, 228, May 2022.
17. Masanori Tamaki, 宮上 慎司, Ikuko Shimizu, 山口 純代, Masanori Minato, Sayo Ueda, Eriko Shibata, Motoyuki Tamaki, Motoyuki Tamaki, Kazuhiro Hasegawa, Kojiro Nagai and Shu Wakino :
ESAからロキサデュスタットへ切り替えた保存期CKD症例の解析,
Japanese Journal of Nephrology, Vol.64, No.3, 257, May 2022.
18. Kazuhiro Hasegawa, Masanori Tamaki, 坂巻 裕介 and Shu Wakino :
FSGSへのNMN短期集中投与はNMN・NAD消費酵素の暴走連関を抑制し糸球体硬化を抑止する,
Japanese Journal of Nephrology, Vol.64, No.3, 263, May 2022.
19. 菅野 義彦 and Shu Wakino :
Minor nutrientsの管理 日本臨床栄養学会の活動,
Journal of Japanese Society for Dialysis Therapy, Vol.55, No.Suppl.1, 299, May 2022.
20. Shu Wakino and 岡田 一義 :
透析専門医の地域偏在解消に向けての取り組み,
Journal of Japanese Society for Dialysis Therapy, Vol.55, No.Suppl.1, 395, May 2022.
21. Sayo Ueda, Eriko Shibata, Masanori Tamaki, Masanori Minato, 岩城 真帆, Ikuko Shimizu, 山口 純代, 宮上 慎司, Kazuhiro Hasegawa and Shu Wakino :
急性間質性腎炎を認めた敗血症性AKIの症例,
Journal of Japanese Society for Dialysis Therapy, Vol.55, No.Suppl.1, 507, May 2022.
22. Masanori Tamaki, 宮上 慎司, 岩城 真帆, Ikuko Shimizu, 山口 純代, Masanori Minato, Sayo Ueda, Eriko Shibata, Kojiro Nagai, Kazuhiro Hasegawa and Shu Wakino :
腹膜透析導入後に膵癌を発症した1例,
Journal of Japanese Society for Dialysis Therapy, Vol.55, No.Suppl.1, 631, May 2022.
23. Ikuko Shimizu, Masanori Tamaki, 宮上 慎司, 山口 純代, Masanori Minato, Sayo Ueda, Eriko Shibata, Kazuhiro Hasegawa and Shu Wakino :
慢性大動脈解離に伴う慢性DICのため腎代替療法導入に苦慮した1例,
Journal of Japanese Society for Dialysis Therapy, Vol.55, No.Suppl.1, 663, May 2022.
24. 北島 幸枝, 松永 智仁 and Shu Wakino :
Total Nutrition Therapy-RENAL研修会の開催と今後の展望,
Journal of Japanese Society for Dialysis Therapy, Vol.55, No.Suppl1, 725, May 2022.
25. Shu Wakino, 内藤 真規子, 二木 功治, 徳山 博文 and 伊藤 裕 :
代謝制御臓器としての腎臓と肥満 肥満における腎障害の分子機序の解明,
Journal of Japan Society for the Study of Obesity, Vol.27, No.Suppl, 210, Mar. 2022.
26. 神田 武志, 浦井 秀徳, 高橋 利奈, Shu Wakino and 伊藤 裕 :
肥満腎症における内皮レプチンシグナルの役割,
Journal of Japan Society for the Study of Obesity, Vol.27, No.Suppl, 326, Mar. 2022.
27. Masanori Tamaki, 宮上 慎司, 岩城 真帆, 清水 郁子, 山口 純代, 湊 将典, Sayo Ueda, Eriko Shibata, Kazuhiro Hasegawa, Kojiro Nagai and Shu Wakino :
膵癌を合併した腹膜透析患者の1例,
第27回日本腹膜透析医学会学術集会・総会, Oct. 2021.
28. 宮上 慎司, Masanori Tamaki, Kenji Nishimura, 岩城 真帆, 清水 郁子, 山口 純代, Sayo Ueda, Eriko Shibata, Hideharu Abe, Kojiro Nagai and Shu Wakino :
繰り返す菌血症に対し予防的抗菌薬投与が奏功した1例,
Journal of Japanese Society for Dialysis Therapy, Jun. 2021.
29. Yuichi Takashi, Masashi Ishizu, Shu Wakino, 水口 斉, 島久 登, 田代 学, 宮 恵子, 水口 潤, Akio Kuroda, Toshio Matsumoto, Munehide Matsuhisa and Seiji Fukumoto :
血液透析患者における心不全・動脈硬化・感染のリスク因子としてのFGF23,
第18回日本内分泌学会四国支部学術集会, Sep. 2018.

Et cetera, Workshop:

1. Masanori Tamaki, 湊 将典, 宮上 慎司, 岩城 真帆, 清水 郁子, 山口 純代, Sayo Ueda, Eriko Shibata, Kazuhiro Hasegawa and Shu Wakino :
ステントグラフト留置術がAVG頻回閉塞に有用であった一例,
第55回四国透析療法研究会, Oct. 2021.
2. 遠藤 理子, 宮上 慎司, 湊 将典, Masanori Tamaki, 岩城 真帆, 清水 郁子, 山口 純代, Sayo Ueda, Eriko Shibata, Kazuhiro Hasegawa and Shu Wakino :
膜性腎症に合併したIgG4関連腎臓病の一例,
第263回徳島医学会, Aug. 2021.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

  • 多元的フェロトーシス治療に基づく慢性腎臓病治療戦略の開発 (Project/Area Number: 23K07674 )
  • Spiral progression of DNA damage repair, epigenetic alterations and metabolic changes in metabolic kidney diseases (Project/Area Number: 20H00535 )
  • Pathophysiology of obesity related glomerulopathy (Project/Area Number: 18K08218 )
  • The significant role of the kidney as a central organ for metabolic organ interrelationship (Project/Area Number: 17H01562 )
  • The pathophysiology of diabetic tubulopathy and therapeutic application (Project/Area Number: 16H05315 )
  • The therapeutic starategy by Ghrelin targeting against mitochondria dynamics (Project/Area Number: 26670433 )
  • Pathophysiology of non-diabetic/obesity induced renal injuries (Project/Area Number: 26461236 )
  • Tubular- glomerular interaction nd metabolic kidney disease (Project/Area Number: 26253053 )
  • The role of endothelial leptin receptor in lifestyle-related diseases. (Project/Area Number: 25461396 )
  • The significance of proximal tubular lesion in diabetic nephropathy and obesity-related glomerulopathy (Project/Area Number: 25293197 )
  • The role of stretch signal induced by the adipocytes hypertrophy and activation of Rho/Rho kinase pathway in the pathogenesis of obesity (Project/Area Number: 22591017 )
  • Therapeutic strategy for chronic kidney disease and hypertension based on time/metabolism regulation. (Project/Area Number: 22590915 )
  • Pathophysiological relevance of visceral fat and kidneys in obesity-induced renal injury (Project/Area Number: 22590898 )
  • Regulation of cell-metabolism by cardiovascular hormones and the comprehensive application to metabolic syndrome. (Project/Area Number: 21390286 )
  • Metabolism of ADMA, a novel risk factor of cardiovascular diseases and its pathophysiological role (Project/Area Number: 20590582 )
  • Anti-aging therapy against chronic kidney disease (Project/Area Number: 19590963 )
  • Cardiovascular-endocrinological approach for elucidation of the molecular mechanism of "Metabo-aging" (Project/Area Number: 19390255 )
  • The role of Rho/Rho kinase pathway in the metabolic syndrome-associated renal insufficiency (Project/Area Number: 18590904 )
  • The investigation of inducing factors of cardiovascular events in early stage of chronic kidney disease (Project/Area Number: 16590716 )
  • Search by Researcher Number (50265823)